B12-based imaging technologies have been investigated in the last 30 years, and different studies have shown strong binding to receptors like megalin in the kidneys and significant tumor uptake with radiolabeled forms, such as [111In]In-DAC and [99mTc]Tc-DTPA-b-cyanocobalamin. The gene discussed is LRP2; the disease is neoplasm.